Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of Low-dose Intra-articular Tranexamic Acid in Total Knee Replacement

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* patients diagnosed as primary knee osteoarthritis and underwent unilateral primary cemented conventional total knee replacement~* no risk of abnormal bleeding tendency or bleeding disorder (normal coagulogram, serum creatinine \< 2.0 mg/dL, stop nonsteroidal anti-inflammatory drugs and antiplatelet drugs more than 7 days~* no contra-indication for tranexamic acid use (no active intravascular clotting process, no acquired defective colour vision, no subarachnoid hemorrhage, no hypersensitivity to TXA, and no any of history of serious adverse effects, thrombotic disorder and hematuria)~Exclusion Criteria:~* incomplete data collection, for example, malfunctioned drain or accidental drain removal.

- Gender: ALL
- Minimum Age: 50 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Control group (Type: PLACEBO_COMPARATOR): physiologic saline 25 ml
- TXA-250 group (Type: ACTIVE_COMPARATOR): A total of 25-ml solution with 250-mg tranexamic acid
- TXA-500 group (Type: ACTIVE_COMPARATOR): A total of 25-ml solution with 500-mg tranexamic acid

Based on this trial design, predict the completion outcome and termination type (if applicable).